Back to
NORTHERN TRUST CORP
BBOT4 quarters
Position history for
NORTHERN TRUST CORP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT
NORTHERN TRUST CORP holds 186,482 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $1.4M as of 2026-Q2. The position was increased (+82.4% shares). BBOT represents 0.0% of NORTHERN TRUST CORP's portfolio.
Current Value
$1.4M
Current Shares
186,482
Total Value Change
+$309,811
Total Shares Change
+90,525
Quarter-by-Quarter History
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC